chr9-121020778-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001317163.2(C5):​c.1321-599A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.525 in 152,080 control chromosomes in the GnomAD database, including 21,269 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.52 ( 21269 hom., cov: 32)

Consequence

C5
NM_001317163.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.721

Publications

7 publications found
Variant links:
Genes affected
C5 (HGNC:1331): (complement C5) This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015]
C5 Gene-Disease associations (from GenCC):
  • complement component 5 deficiency
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.762 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001317163.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
C5
NM_001735.3
MANE Select
c.1303-599A>C
intron
N/ANP_001726.2
C5
NM_001317163.2
c.1321-599A>C
intron
N/ANP_001304092.1
C5
NM_001317164.2
c.1303-599A>C
intron
N/ANP_001304093.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
C5
ENST00000223642.3
TSL:1 MANE Select
c.1303-599A>C
intron
N/AENSP00000223642.1
C5
ENST00000696281.1
c.1321-599A>C
intron
N/AENSP00000512521.1
C5
ENST00000867873.1
c.1303-599A>C
intron
N/AENSP00000537932.1

Frequencies

GnomAD3 genomes
AF:
0.525
AC:
79708
AN:
151962
Hom.:
21240
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.461
Gnomad AMI
AF:
0.669
Gnomad AMR
AF:
0.564
Gnomad ASJ
AF:
0.577
Gnomad EAS
AF:
0.782
Gnomad SAS
AF:
0.667
Gnomad FIN
AF:
0.578
Gnomad MID
AF:
0.509
Gnomad NFE
AF:
0.511
Gnomad OTH
AF:
0.536
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.525
AC:
79790
AN:
152080
Hom.:
21269
Cov.:
32
AF XY:
0.530
AC XY:
39392
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.462
AC:
19149
AN:
41468
American (AMR)
AF:
0.564
AC:
8624
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.577
AC:
2003
AN:
3472
East Asian (EAS)
AF:
0.782
AC:
4047
AN:
5176
South Asian (SAS)
AF:
0.667
AC:
3217
AN:
4822
European-Finnish (FIN)
AF:
0.578
AC:
6103
AN:
10562
Middle Eastern (MID)
AF:
0.503
AC:
148
AN:
294
European-Non Finnish (NFE)
AF:
0.511
AC:
34750
AN:
67976
Other (OTH)
AF:
0.539
AC:
1139
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1967
3934
5900
7867
9834
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
710
1420
2130
2840
3550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.451
Hom.:
2420
Bravo
AF:
0.520
Asia WGS
AF:
0.697
AC:
2424
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
10
DANN
Benign
0.42
PhyloP100
0.72
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2159777; hg19: chr9-123783056; API